COVID-19-Pandemie: Effekte auf die klinische Versorgung von Herz-Kreislauf-Patienten im Frühling 2020

por Zeymer, Uwe, Gitt, Anselm, Thiele, Holger
Publicado 2021

Prevalence and overlap of different lipid abnormalities in statin-treated patients at high cardiovascular risk in clinical practice in Germany

por Gitt, Anselm K., Jünger, Claus, Smolka, Wenefrieda, Bestehorn, Kurt
Publicado 2010

A real world comparison of sulfonylurea and insulin vs. incretin-based treatments in patients not controlled on prior metformin monotherapy

por Gitt, Anselm K, Bramlage, Peter, Schneider, Steffen, Tschöpe, Diethelm
Publicado 2015

Management of the COVID-19 pandemic in Rhineland-Palatinate hospitals of all levels of care: Results of the COVID-19 Registry RLP

por Gitt, Anselm K., Horack, Martin, Schneider, Steffen, Zeymer, Uwe, Zahn, Ralf
Publicado 2023

Clinical course and outcomes of type-2 diabetic patients after treatment intensification for insufficient glycaemic control - results of the 2 year prospective DiaRegis follow-up

por Bramlage, Peter, Gitt, Anselm K, Schneider, Steffen, Deeg, Evelin, Tschöpe, Diethelm
Publicado 2014

Treatment patterns and risk factor control in patients with and without metabolic syndrome in cardiac rehabilitation

por Gitt, Anselm, Jannowitz, Christina, Karoff, Marthin, Karmann, Barbara, Horack, Martin, Völler, Heinz
Publicado 2012

Individualised treatment targets in patients with type-2 diabetes and hypertension

por Schmieder, Roland E., Tschöpe, Diethelm, Koch, Cornelia, Ouarrak, Taoufik, Gitt, Anselm K.
Publicado 2018

Oral antidiabetic treatment in type-2 diabetes in the elderly: balancing the need for glucose control and the risk of hypoglycemia

por Bramlage, Peter, Gitt, Anselm K, Binz, Christiane, Krekler, Michael, Deeg, Evelin, Tschöpe, Diethelm
Publicado 2012

Incidence and predictors of hypoglycaemia in type 2 diabetes – an analysis of the prospective DiaRegis registry

por Tschöpe, Diethelm, Bramlage, Peter, Binz, Christiane, Krekler, Michael, Deeg, Evelin, Gitt, Anselm K
Publicado 2012

Achievement of recommended glucose and blood pressure targets in patients with type 2 diabetes and hypertension in clinical practice – study rationale and protocol of DIALOGUE

por Gitt, Anselm K, Schmieder, Roland E, Duetting, Eva, Bramlage, Peter, Schneider, Steffen, Tschöpe, Diethelm
Publicado 2012

Achievement of individualized treatment targets in patients with comorbid type-2 diabetes and hypertension: 6 months results of the DIALOGUE registry

por Schmieder, Roland E, Gitt, Anselm K, Koch, Cornelia, Bramlage, Peter, Ouarrak, Taoufik, Tschöpe, Diethelm
Publicado 2015

Diabetes treatment patterns and goal achievement in primary diabetes care (DiaRegis) - study protocol and patient characteristics at baseline

por Bramlage, Peter, Binz, Christiane, Gitt, Anselm K, Krekler, Michael, Plate, Tanja, Deeg, Evelin, Tschöpe, Diethelm
Publicado 2010

Antidiabetic pharmacotherapy and anamnestic hypoglycemia in a large cohort of type 2 diabetic patients - an analysis of the DiaRegis registry

por Tschöpe, Diethelm, Bramlage, Peter, Binz, Christiane, Krekler, Michael, Plate, Tanja, Deeg, Evelin, Gitt, Anselm K
Publicado 2011

Co-morbidity but not dysglycaemia reduces quality of life in patients with type-2 diabetes treated with oral mono- or dual combination therapy – an analysis of the DiaRegis registr...

por Wasem, Jürgen, Bramlage, Peter, Gitt, Anselm K, Binz, Christiane, Krekler, Michael, Deeg, Evelin, Tschöpe, Diethelm
Publicado 2013

The COVID-19 Registry in Rhineland-Palatinate in the context of international registry activities documenting COVID-19 outcomes

por Gitt, Anselm K., Bernhardt, Alexandra, Zahn, Ralf, Zeymer, Uwe, Grau, Armin, Beutel, Manfred E., Werdan, Karl
Publicado 2020

Hypercholesterolemia Diagnosis, Treatment Patterns, and 12-Month Target Achievement in Clinical Practice in Germany in Patients with Familial Hypercholesterolemia

por Gitt, Anselm K., Laufs, Ulrich, März, Winfried, Paar, W. Dieter, Bramlage, Peter, Marx, Nikolaus, Parhofer, Klaus G.
Publicado 2022

Lipid management in 13,000 high risk cardiovascular patients treated under daily practice conditions: LIMA Registry

por Schaefer, Juergen R, Gitt, Anselm K, Sonntag, Frank, Weizel, Achim, Jannowitz, Christina, Karmann, Barbara, Pittrow, David, Bestehorn, Kurt
Publicado 2013

The role of co-morbidity in the selection of antidiabetic pharmacotherapy in type-2 diabetes

por Tschöpe, Diethelm, Hanefeld, Markolf, Meier, Juris J, Gitt, Anselm K, Halle, Martin, Bramlage, Peter, Schumm-Draeger, Petra-Maria
Publicado 2013

EARLY Treatment with azilsartan compared to ACE-inhibitors in anti-hypertensive therapy – rationale and design of the EARLY hypertension registry

por Gitt, Anselm K, Baumgart, Peter, Bramlage, Peter, Mahfoud, Felix, Potthoff, Sebastian A, Senges, Jochen, Schneider, Steffen, Buhck, Hartmut, Schmieder, Roland E
Publicado 2013

The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights...

por Bramlage, Peter, Schmieder, Roland E., Gitt, Anselm K., Baumgart, Peter, Mahfoud, Felix, Buhck, Hartmut, Ouarrak, Taoufik, Ehmen, Martina, Potthoff, Sebastian A.
Publicado 2015